Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TMPRSS2 Antibody (Center) Blocking Peptide | Login | TMPRSS2 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MYCN Antibody (C-term) Blocking Peptide | Login | MYCN Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| RAD21 Antibody (C-term) Blocking Peptide | Login | RAD21 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MEN1 Antibody (S128) Blocking Peptide | Login | MEN1 Antibody (S128) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MEN1 Antibody (T594) Blocking Peptide | Login | MEN1 Antibody (T594) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| SAST Blocking Peptide (N-term) | Login | SAST Blocking Peptide (N-term) | ||||||||||||||||
|
||||||||||||||||||
| MAPK1 Blocking Peptide (Center) | Login | MAPK1 Blocking Peptide (Center) | ||||||||||||||||
|
||||||||||||||||||
| NFE2L2 Blocking Peptide (N-term) | Login | NFE2L2 Blocking Peptide (N-term) | ||||||||||||||||
|
||||||||||||||||||
| CHK1 Blocking Peptide (Center) | Login | CHK1 Blocking Peptide (Center) | ||||||||||||||||
|
||||||||||||||||||
| EphB6 Antibody (N-term E-121) Blocking Peptide | Login | EphB6 Antibody (N-term E-121) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| EphB6 Antibody ( C-term V897) Blocking Peptide | Login | EphB6 Antibody ( C-term V897) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| GUCY2C Antibody (Center) Blocking Peptide | Login | GUCY2C Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| GUCY2C Antibody (C-term) Blocking Peptide | Login | GUCY2C Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AKT1 Antibody (N-term) Blocking Peptide | Login | AKT1 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AKT1 Antibody (S246) Blocking Peptide | Login | AKT1 Antibody (S246) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AKT1 Antibody (S124) Blocking Peptide | Login | AKT1 Antibody (S124) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AKT1 Antibody (C-term) Blocking Peptide | Login | AKT1 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| AKT1 Antibody (N-term) Blocking Peptide | Login | AKT1 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MAP3K15 Antibody (N-term) Blocking Peptide | Login | MAP3K15 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MELK Antibody (Center) Blocking Peptide | Login | MELK Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MELK Antibody (C-term) Blocking Peptide | Login | MELK Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| NUAK2 Antibody (N-term) Blocking Peptide | Login | NUAK2 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PBK Antibody (N-term) Blocking Peptide | Login | PBK Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PBK Antibody (C-term) Blocking Peptide | Login | PBK Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| PBK Antibody (N-term N6) Blocking Peptide | Login | PBK Antibody (N-term N6) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||


